Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 127.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 350.00
  • 52 Week Low: 117.50
  • Currency: UK Pounds
  • Shares Issued: 72.01m
  • Volume: 1,513
  • Market Cap: £91.81m

ShareCast News

FDA approves next two phases of Faron's Traumaki... 26-Jan-2021 ShareCast
Faron gets Traumakine funding from US Department... 18-Jan-2021 ShareCast
Faron Pharmaceuticals gets Finnish state loan fo... 15-Jun-2020 ShareCast
Faron receives EIC grant for 'MATINS' study 11-Jun-2020 ShareCast
Faron Pharmaceuticals confirms publication of 'c... 20-May-2020 ShareCast
Faron Pharmaceuticals inks manufacturing deal wi... 05-May-2020 ShareCast
Faron gets FDA tick from proposed design of next... 09-Mar-2020 ShareCast
Faron Pharmaceuticals acquires rights to AOC3 in... 02-Mar-2020 ShareCast
Faron Pharma requests arbitration over Traumakin... 30-Dec-2019 ShareCast
Faron Pharmaceuticals upbeat on new data from 'M... 11-Dec-2019 ShareCast
Faron Pharmaceuticals positive on feedback from ... 09-Oct-2019 ShareCast
Faron Pharmaceuticals hits bump in road for Trau... 02-Oct-2019 ShareCast
Faron Pharma raises ?2.3m to keep it going throu... 27-Aug-2019 ShareCast
Faron Pharmaceuticals reports 'significant' find... 14-Jun-2019 ShareCast
Faron appoints new CFO after some internal shuff... 24-May-2019 ShareCast
Faron Pharmaceuticals upbeat on latest info from... 11-Apr-2019 ShareCast
Faron Pharmaceuticals shares surge on latest Cle... 21-Feb-2019 ShareCast
Faron Pharmaceuticals pins some hope to YODA trial 19-Dec-2018 ShareCast
Dosing begins in Faron's study of 'Clevegen' drug 14-Dec-2018 ShareCast
Traumakine treatment optimal for particular subg... 05-Dec-2018 ShareCast
Faron Pharmaceuticals applies to begin Clevegen ... 03-Dec-2018 ShareCast
Faron losses widen following disappointing Traum... 13-Sep-2018 ShareCast
Faron 'encouraged' by latest Clevegen study 28-Jun-2018 ShareCast
Faron sees some encouraging data in ongoing INTE... 14-Jun-2018 ShareCast
Faron Pharma trial returns unexpected results 11-May-2018 ShareCast
Faron Pharmaceuticals crashes on results of disa... 08-May-2018 ShareCast
Faron Pharma to raise £15m for Traumakine invest... 16-Feb-2018 ShareCast
Faron's Traumakine approved as investigational n... 24-Jan-2018 ShareCast
Faron says Traumakine trial on track as it expan... 11-Dec-2017 ShareCast
AstraZeneca's Juhana Heinonen on the move to Faron 01-Dec-2017 ShareCast
Faron's 'Traumakine' set for swift progress thro... 04-Sep-2017 ShareCast
Faron's 'Traumakine' set for swift progress thro... 04-Sep-2017 ShareCast
Faron looks at compassionate use programme as IN... 04-Aug-2017 ShareCast
Faron Pharmaceuticals widens operating loss as d... 29-Mar-2017 ShareCast
Faron recruits first patient for new Traumakine ... 20-Feb-2017 ShareCast
Faron Pharmaceuticals makes solid progress with ... 09-Feb-2017 ShareCast
Faron Pharma granted protection for IFN-beta by ... 31-Oct-2016 ShareCast
Faron Pharma raises £8m to fund R&D 21-Sep-2016 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 127.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 350.00
52 Week Low 117.50
Volume 1,513
Shares Issued 72.01m
Market Cap £91.81m

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 1
Strong Sell 1
Total 3
sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:00 1,184 @ 125.60p
10:12 15 @ 135.00p
08:42 314 @ 135.00p

FARN Key Personnel

CEO Markku Jalkanen
Chair Tuomo Pätsi

Top of Page